lomustine has been researched along with Lymphoma in 53 studies
Lymphoma: A general term for various neoplastic diseases of the lymphoid tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Lomustine, vincristine, procarbazine and prednisolone (LOPP) chemotherapy has been suggested to be an effective treatment for dogs with naïve non-indolent T-cell lymphoma (TCL)." | 8.12 | Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy. ( Blaxill, J; Buzzacott, P; Finlay, J, 2022) |
| "The optimal high-dose methotrexate (HDMTX)-based combination therapy for primary central nervous system lymphoma is unknown." | 8.12 | Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma. ( Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E, 2022) |
| " The objective of the present study was to investigate if a shorter protocol combined with an oral lomustine maintenance treatment (3 × in 8 weeks) would present an acceptable result, both for B- and T-cell lymphomas, and for the different types of lymphomas normally encountered in private veterinary practice." | 8.12 | Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma. ( Eberle, N; Limmer, S; Nerschbach, V; Simon Betz, D; Teske, E, 2022) |
| "The aim of this study was to assess the efficacy and tolerability of lomustine, methotrexate and cytarabine chemotherapy as rescue treatment for feline lymphoma." | 8.02 | Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. ( Blackwood, L; Harper, A; Smallwood, K, 2021) |
| "This retrospective study evaluated the use of lomustine as a rescue agent for 39 cases of resistant feline lymphoma." | 7.78 | Evaluation of lomustine as a rescue agent for cats with resistant lymphoma. ( Bulman-Fleming, JC; Dutelle, AL; Lewis, CA; Rosenberg, MP, 2012) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 7.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "To assess response rate, median duration of response, adverse effects, and prognostic factors associated with concurrent administration of lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma." | 7.74 | Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005). ( Bannink, EO; Kaneene, JB; Mullins, MN; Obradovich, JE; Sauerbrey, ML; Van Dorp, TE, 2007) |
| "The preparatory regimen consisting of lomustine/etoposide/cyclophosphamide is active in treating patients with lymphomas." | 5.08 | A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma. ( Blaschke, TF; Blume, KG; Chao, NJ; Horning, SJ; Kastrissios, H; Long, GD; Negrin, RS; Wong, RM, 1995) |
| "Lomustine, vincristine, procarbazine and prednisolone (LOPP) chemotherapy has been suggested to be an effective treatment for dogs with naïve non-indolent T-cell lymphoma (TCL)." | 4.12 | Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy. ( Blaxill, J; Buzzacott, P; Finlay, J, 2022) |
| "The optimal high-dose methotrexate (HDMTX)-based combination therapy for primary central nervous system lymphoma is unknown." | 4.12 | Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma. ( Avni, B; Gatt, ME; Goldschmidt, N; Grisaro, S; Gural, A; Lavie, D; Lebel, E; Linetski, E; Lossos, A; Makranz, C; Nachmias, B; Rosenberg, S; Saban, R; Shaulov, A; Siegal, T; Vainstein, V; Zimran, E, 2022) |
| " The objective of the present study was to investigate if a shorter protocol combined with an oral lomustine maintenance treatment (3 × in 8 weeks) would present an acceptable result, both for B- and T-cell lymphomas, and for the different types of lymphomas normally encountered in private veterinary practice." | 4.12 | Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma. ( Eberle, N; Limmer, S; Nerschbach, V; Simon Betz, D; Teske, E, 2022) |
| "The aim of this study was to assess the efficacy and tolerability of lomustine, methotrexate and cytarabine chemotherapy as rescue treatment for feline lymphoma." | 4.02 | Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma. ( Blackwood, L; Harper, A; Smallwood, K, 2021) |
| " Lymphoma was the most common cancer diagnosis; lomustine and vinca alkaloids were the most frequently implicated causative agents." | 3.85 | Febrile neutropenia in cats treated with chemotherapy. ( Barber, L; Boudreaux, B; DeRegis, C; Flory, A; Krick, E; Pierro, J; Regan, R; Saam, D; Saba, C, 2017) |
| "This retrospective study evaluated the use of lomustine as a rescue agent for 39 cases of resistant feline lymphoma." | 3.78 | Evaluation of lomustine as a rescue agent for cats with resistant lymphoma. ( Bulman-Fleming, JC; Dutelle, AL; Lewis, CA; Rosenberg, MP, 2012) |
| "To evaluate the toxicity and efficacy of a modification of a previously evaluated combination of lomustine, vincristine, procarbazine, and prednisone (LOPP) as a rescue protocol for refractory lymphoma in dogs." | 3.77 | Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009). ( Barabas, K; Clemente, M; Fahey, CE; Kow, K; Lurie, D; Lyles, S; Milner, RJ; Parfitt, S, 2011) |
| "To assess response rate, median duration of response, adverse effects, and prognostic factors associated with concurrent administration of lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma." | 3.74 | Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005). ( Bannink, EO; Kaneene, JB; Mullins, MN; Obradovich, JE; Sauerbrey, ML; Van Dorp, TE, 2007) |
| "Nineteen patients with advanced non-Hodgkin's lymphoma resistant to previous chemotherapy were treated with combination chemotherapy consisting of lomustine (CCNU), cytarabine, and prednisone." | 3.66 | Salvage chemotherapy for non-Hodgkin's lymphoma. ( Khoo, RK; Ng, PR; Todd, D, 1982) |
| "Necropsy identified severe diffuse pulmonary fibrosis and no signs of lymphoma." | 1.35 | Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat. ( Duda, L; Durham, AC; Skorupski, KA; Sørenmo, KU, 2008) |
| "38 cats with measurable, histologically or cytologically confirmed MCTs treated with lomustine at a dosage > or = 50 mg/m(2)." | 1.35 | Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). ( Al-Sarraf, R; Baez, JL; Dank, G; Kristal, O; Rassnick, KM; Williams, LE; Zwahlen, CH, 2008) |
| "12 patients with brain tumors were treated with a combination of procarbazine, CCNU (bis-2-chloroethyl-3-cyclohexyl-1-nitrosourea) and vincristine." | 1.27 | Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors. ( Biran, S; Brufman, G; Catane, R; Halpern, J; Sulkes, A, 1984) |
| " The three drugs show similar threshold-type dose-response survival curves on asynchronous cells treated for 1 hr." | 1.26 | A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells. ( Drewinko, B; Gottlieb, JA; Loo, TL, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (49.06) | 18.7374 |
| 1990's | 1 (1.89) | 18.2507 |
| 2000's | 6 (11.32) | 29.6817 |
| 2010's | 13 (24.53) | 24.3611 |
| 2020's | 7 (13.21) | 2.80 |
| Authors | Studies |
|---|---|
| Farmer, PB | 1 |
| Foster, AB | 2 |
| Jarman, M | 2 |
| Oddy, MR | 1 |
| Reed, DJ | 1 |
| Coe, PL | 1 |
| Sleigh, J | 1 |
| Tatlow, JC | 1 |
| Blaxill, J | 1 |
| Buzzacott, P | 1 |
| Finlay, J | 1 |
| Leal, CTS | 1 |
| Costa, LJM | 2 |
| Pereira, J | 3 |
| Duarte, FB | 1 |
| Tavares, RB | 1 |
| Atalla, A | 2 |
| Sabioni, BS | 1 |
| Neto, AEH | 1 |
| Lebel, E | 1 |
| Goldschmidt, N | 1 |
| Siegal, T | 1 |
| Lossos, A | 1 |
| Rosenberg, S | 1 |
| Makranz, C | 1 |
| Linetski, E | 1 |
| Gatt, ME | 1 |
| Gural, A | 1 |
| Saban, R | 1 |
| Lavie, D | 1 |
| Vainstein, V | 1 |
| Zimran, E | 1 |
| Avni, B | 1 |
| Grisaro, S | 1 |
| Shaulov, A | 1 |
| Nachmias, B | 1 |
| Limmer, S | 2 |
| Nerschbach, V | 2 |
| Eberle, N | 2 |
| Teske, E | 2 |
| Simon Betz, D | 2 |
| Kelsey, P | 1 |
| Pearce, R | 1 |
| Perry, J | 1 |
| Kirkland, K | 1 |
| Paul, R | 1 |
| Lambert, J | 2 |
| Peniket, A | 1 |
| Malladi, R | 1 |
| Snowden, JA | 1 |
| Morley, N | 1 |
| Gieger, TL | 1 |
| Seiler, GS | 1 |
| Nolan, MW | 1 |
| Smallwood, K | 1 |
| Harper, A | 1 |
| Blackwood, L | 1 |
| Dos Santos, KB | 2 |
| Bettarello, G | 1 |
| da Matta Abreu, M | 1 |
| Mayrink, GTC | 1 |
| Mota, MA | 1 |
| Ribeiro, LC | 1 |
| Hallack Neto, AE | 1 |
| Maybury, B | 1 |
| Kimpton, G | 1 |
| Otton, S | 1 |
| Doyle, AJ | 1 |
| MacDonald, VS | 1 |
| Bourque, A | 1 |
| Shih, JL | 1 |
| Brenn, S | 1 |
| Schrope, DP | 1 |
| Costa, LJ | 1 |
| Hallack-Neto, AE | 1 |
| Kambayashi, S | 1 |
| Minami, K | 1 |
| Ogawa, Y | 1 |
| Hamaji, T | 1 |
| Hwang, CC | 1 |
| Igase, M | 1 |
| Hiraoka, H | 1 |
| Miyama, TS | 1 |
| Noguchi, S | 1 |
| Baba, K | 1 |
| Mizuno, T | 1 |
| Okuda, M | 1 |
| Pierro, J | 1 |
| Krick, E | 1 |
| Flory, A | 1 |
| Regan, R | 1 |
| DeRegis, C | 1 |
| Boudreaux, B | 1 |
| Barber, L | 1 |
| Saam, D | 1 |
| Saba, C | 1 |
| Kothari, J | 1 |
| Foley, M | 1 |
| Peggs, KS | 1 |
| Mackenzie, S | 1 |
| Thomson, K | 1 |
| Morris, E | 1 |
| Ardeshna, KM | 1 |
| Virchis, AE | 1 |
| Linch, DC | 1 |
| Rau, SE | 1 |
| Burgess, KE | 1 |
| Skorupski, KA | 1 |
| Durham, AC | 1 |
| Duda, L | 1 |
| Sørenmo, KU | 1 |
| Rassnick, KM | 2 |
| Bailey, DB | 1 |
| Malone, EK | 1 |
| Intile, JL | 1 |
| Kiselow, MA | 1 |
| Flory, AB | 1 |
| Barlow, LL | 1 |
| Balkman, CE | 1 |
| Barnard, SM | 1 |
| Waite, AH | 1 |
| Sierra Del Rio, M | 1 |
| Ricard, D | 1 |
| Houillier, C | 1 |
| Navarro, S | 1 |
| Gonzalez-Aguilar, A | 1 |
| Idbaih, A | 1 |
| Kaloshi, G | 1 |
| Elhallani, S | 1 |
| Omuro, A | 1 |
| Choquet, S | 1 |
| Soussain, C | 1 |
| Hoang-Xuan, K | 2 |
| Fahey, CE | 1 |
| Milner, RJ | 1 |
| Barabas, K | 1 |
| Lurie, D | 1 |
| Kow, K | 1 |
| Parfitt, S | 1 |
| Lyles, S | 1 |
| Clemente, M | 1 |
| Dutelle, AL | 1 |
| Bulman-Fleming, JC | 1 |
| Lewis, CA | 1 |
| Rosenberg, MP | 1 |
| Taillandier, L | 1 |
| Chinot, O | 1 |
| Soubeyran, P | 1 |
| Bogdhan, U | 1 |
| Hildebrand, J | 1 |
| Frenay, M | 1 |
| De Beule, N | 1 |
| Delattre, JY | 1 |
| Baron, B | 1 |
| Sauerbrey, ML | 1 |
| Mullins, MN | 1 |
| Bannink, EO | 1 |
| Van Dorp, TE | 1 |
| Kaneene, JB | 1 |
| Obradovich, JE | 1 |
| Williams, LE | 1 |
| Kristal, O | 1 |
| Al-Sarraf, R | 1 |
| Baez, JL | 1 |
| Zwahlen, CH | 1 |
| Dank, G | 1 |
| García López, J | 1 |
| Diumenjo, MC | 1 |
| Argüelles, MV | 1 |
| Marín, P | 1 |
| Grañena, A | 1 |
| Montserrat, E | 1 |
| Rozman, C | 1 |
| Jackson, DV | 1 |
| Muss, HB | 1 |
| Richards, F | 1 |
| White, DR | 1 |
| Spurr, CL | 1 |
| Cooper, MR | 1 |
| Christian, RM | 1 |
| Trahey, TF | 1 |
| Case, LD | 1 |
| Wells, HB | 1 |
| Philip, T | 1 |
| Biron, P | 1 |
| Hervé, P | 1 |
| Dutou, L | 1 |
| Ehrsam, A | 1 |
| Philip, I | 1 |
| Souillet, G | 1 |
| Plouvier, E | 1 |
| Le Mevel, A | 1 |
| Philippe, N | 1 |
| Gorin, NC | 2 |
| Najman, A | 2 |
| Douay, L | 1 |
| Salmon, C | 2 |
| David, R | 2 |
| Stachowiak, J | 2 |
| Parlier, Y | 2 |
| Lopez, M | 1 |
| Oppenheimer, M | 1 |
| Lecomte, D | 1 |
| Brufman, G | 1 |
| Halpern, J | 1 |
| Sulkes, A | 1 |
| Catane, R | 1 |
| Biran, S | 1 |
| Wallenborn, PA | 1 |
| Postma, DS | 1 |
| Heinz, R | 1 |
| Hanak, H | 1 |
| Levine, AM | 1 |
| Forman, SJ | 1 |
| Meyer, PR | 1 |
| Koehler, SC | 1 |
| Liebman, H | 1 |
| Paganini-Hill, A | 1 |
| Pockros, A | 1 |
| Lukes, RJ | 1 |
| Feinstein, DI | 1 |
| Weiss, RB | 1 |
| Issell, BF | 1 |
| Haddad, E | 1 |
| Le Bourgeois, JP | 1 |
| Kuentz, M | 1 |
| Lobo, P | 1 |
| Petit, JC | 1 |
| Duhamel, G | 1 |
| Gibson, NW | 1 |
| Hickman, JA | 1 |
| Ng, PR | 1 |
| Todd, D | 1 |
| Khoo, RK | 1 |
| Chao, NJ | 1 |
| Kastrissios, H | 1 |
| Long, GD | 1 |
| Negrin, RS | 1 |
| Horning, SJ | 1 |
| Wong, RM | 1 |
| Blaschke, TF | 1 |
| Blume, KG | 1 |
| Herrlinger, U | 1 |
| Brugger, W | 1 |
| Bamberg, M | 1 |
| Küker, W | 1 |
| Dichgans, J | 1 |
| Weller, M | 1 |
| Kochi, M | 1 |
| Ushio, Y | 1 |
| Hoogstraten, B | 1 |
| Haas, CD | 1 |
| Haut, A | 1 |
| Talley, RW | 1 |
| Rivkin, S | 1 |
| Isaacs, BL | 1 |
| Nissen, NI | 1 |
| Pajak, T | 1 |
| Glidewell, O | 1 |
| Blom, H | 1 |
| Flaherty, M | 1 |
| Hayes, D | 1 |
| McIntyre, R | 1 |
| Holland, JF | 1 |
| Bistoni, F | 1 |
| Marconi, P | 1 |
| Pitzurra, M | 1 |
| Frati, L | 1 |
| Spreafico, F | 1 |
| Goldin, A | 1 |
| Bonmassar, E | 1 |
| Wasserman, TH | 1 |
| Slavik, M | 1 |
| Carter, SK | 1 |
| Drewinko, B | 1 |
| Loo, TL | 1 |
| Gottlieb, JA | 1 |
| Williams, SF | 1 |
| Ultmann, JE | 1 |
| Gaynor, E | 1 |
| Watson, S | 1 |
| Dutcher, JP | 1 |
| Wiernik, PH | 1 |
| Straus, DJ | 1 |
| Grossberg, H | 1 |
| Opfell, R | 1 |
| Glick, J | 1 |
| Bakemeier, R | 1 |
| Schnetzer, G | 1 |
| Muggia, F | 1 |
| Tisdale, MJ | 1 |
| Brennan, RA | 1 |
| Connors, TA | 1 |
| Hare, JR | 1 |
5 reviews available for lomustine and Lymphoma
| Article | Year |
|---|---|
The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
Topics: Bone Marrow; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Gastrointestinal Neoplasms; Hod | 1982 |
[Chemo-radiotherapy for malignant brain tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Central Nervous System | 2002 |
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Topics: Adult; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug The | 1977 |
Clinical comparison of the nitrosoureas.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Carmustine; Chemical Phenomena; C | 1975 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
8 trials available for lomustine and Lymphoma
| Article | Year |
|---|---|
LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Et | 2019 |
Comparison between L-CHOP and an L-CHOP protocol with interposed treatments of CCNU and MOPP (L-CHOP-CCNU-MOPP) for lymphoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparagine; Cyclophosphamide; Dog Diseases; | 2010 |
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Belgium; Biops | 2003 |
CCNU in combination chemotherapy for advanced histologically unfavorable non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C | 1983 |
A new preparatory regimen for autologous bone marrow transplantation for patients with lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Comb | 1995 |
PCV salvage chemotherapy for recurrent primary CNS lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Huma | 2000 |
Overview of four clinical studies of chemotherapy for stage III and IV non-Hodgkin's lymphomas by the Cancer and Leukemia Group B.
Topics: Adult; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Drug Administration Schedule; Drug The | 1977 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top | 1989 |
42 other studies available for lomustine and Lymphoma
| Article | Year |
|---|---|
Synthesis, metabolism, and antitumor activity of deuterated analogues of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Topics: Animals; Antineoplastic Agents; Chromatography, High Pressure Liquid; Deuterium; In Vitro Techniques | 1978 |
Fluorinated analogues of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea: an attempt to control metabolism.
Topics: Animals; Antineoplastic Agents; Female; Leukemia L1210; Lomustine; Lymphoma; Mice; Neoplasms, Experi | 1980 |
Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Hypercalcemia; Lomustin | 2022 |
Maximum-tolerated dose of lomustine used in combination with etoposide and cyclophosphamide in conditioning regimen for hematopoietic stem cell transplantation in lymphoma patients.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell | 2022 |
Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Central Nervous System; Central Nervous System Neopl | 2022 |
Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Lomustine; Lymphoma; Ly | 2022 |
Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Lomustine; Lymphoma; Ly | 2022 |
Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Lomustine; Lymphoma; Ly | 2022 |
Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Lomustine; Lymphoma; Ly | 2022 |
Substituting carmustine for lomustine is safe and effective in the treatment of relapsed or refractory Lymphoma-a retrospective study from the BSBMT (BEAM versus LEAM).
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Humans; Lomustine | 2021 |
Treatment of feline gastrointestinal intermediate- or large-cell lymphoma with lomustine chemotherapy and 8 Gy abdominal cavity radiation therapy.
Topics: Abdominal Cavity; Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Gastr | 2021 |
Lomustine, methotrexate and cytarabine chemotherapy as a rescue treatment for feline lymphoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cat Diseases; Cats; Cyclophosphamide; Cytar | 2021 |
A retrospective multicentre study of COCKLE, an oral chemotherapy regimen, as palliative treatment for high grade lymphoma.
Topics: Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclo | 2019 |
Use of lomustine (CCNU) in a case of cutaneous equine lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Drug Therapy, Combinati | 2013 |
Cardiac involvement secondary to mediastinal lymphoma in a cat: regression with chemotherapy.
Topics: Animals; Anticonvulsants; Antineoplastic Agents; Asparaginase; Cat Diseases; Cats; Drug Therapy, Com | 2014 |
Lomustine use in combination with etoposide, cytarabine and melphalan in a brief conditioning regimen for auto-HSCT in patients with lymphoma: the optimal dose.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cohort Studies; Cytarabine; Etopo | 2014 |
Expression of O(6)-methylguanine-DNA methyltransferase causes lomustine resistance in canine lymphoma cells.
Topics: Animals; Antineoplastic Agents; CpG Islands; DNA Modification Methylases; Dog Diseases; Dogs; Drug R | 2015 |
Febrile neutropenia in cats treated with chemotherapy.
Topics: Animals; Antineoplastic Agents; Cat Diseases; Cats; Febrile Neutropenia; Female; Leukocyte Count; Lo | 2017 |
A retrospective comparison of toxicity and initial efficacy of two autologous stem cell transplant conditioning regimens for relapsed lymphoma: LEAM and BEAM.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Etoposide; Female; Hematopoi | 2016 |
A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Female; Gastrointestinal Neoplasms; | 2017 |
Pulmonary fibrosis after high cumulative dose nitrosourea chemotherapy in a cat.
Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Fatal Outco | 2008 |
Prophylactic intrathecal chemotherapy in primary CNS lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Agents; | 2012 |
Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Drug Resistance, Neopla | 2011 |
Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Drug Resistance, Neoplasm; Female; L | 2012 |
Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Dog Diseases; Dogs; Dos | 2007 |
Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005).
Topics: Animals; Antineoplastic Agents, Alkylating; Cat Diseases; Cats; Female; Kaplan-Meier Estimate; Lomus | 2008 |
[CCNU, bleomycin, and vincristine (vinblastine) combination therapy in the treatment of resistant lymphoma (author's transl)].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgki | 1980 |
Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carm | 1983 |
Autologous bone marrow transplantation in the treatment of poor prognosis non-Hodgkin's lymphomas.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Combined Modality Thera | 1984 |
Procarbazine, CCNU and vincristine (PCV) combination chemotherapy for brain tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modali | 1984 |
Radiation recall supraglottitis. A hazard in head and neck chemotherapy.
Topics: Cytarabine; Epiglottitis; Head and Neck Neoplasms; Humans; Laryngitis; Lomustine; Lymphoma; Male; Mi | 1984 |
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis | 1984 |
Successful therapy of convoluted T-lymphoblastic lymphoma in the adult.
Topics: Adolescent; Adult; Asparaginase; Brain; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; I | 1983 |
Liver complications in lymphomas treated with a combination of chemotherapy and radiotherapy: preliminary results.
Topics: Adult; Aged; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Liver; Lomusti | 1983 |
High dose chemotherapy and autologous bone marrow transplantation in acute leukemias, malignant lymphomas and solid tumors. A study of 23 patients.
Topics: Adolescent; Adult; Bone Marrow Transplantation; Cyclophosphamide; Cytarabine; Drug Therapy, Combinat | 1981 |
The role of isocyanates in the toxicity of antitumour haloalkylnitrosoureas.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyanates; Female; Leukemia L1210; Lomustine; Lymphoma; M | 1982 |
Salvage chemotherapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Cytarabine; Drug Therapy, Combination; Female; Humans; Leukopenia; Lomustine; Lymphoma; | 1982 |
CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Bleomycin; Bone Marrow Cells; Carcinoma, Squamous Cell; Dose-Response Relationship, | 1975 |
Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
Topics: Adjuvants, Immunologic; Animals; Antineoplastic Agents; BCG Vaccine; Candida albicans; Carmustine; D | 1979 |
A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells.
Topics: Amphotericin B; Carmustine; Cell Line; Cell Survival; Cells, Cultured; Dose-Response Relationship, D | 1976 |
Management of advanced, resistant Hodgkin's disease and non-Hodgkin's lymphoma: a phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Drug Evaluation; | 1986 |
Acute leukemia in a patient cured of diffuse histiocytic lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Deletion; Chromosomes, Human, | 1986 |
Treatment of advanced refractory lymphoma with teniposide and lomustine.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Female; Humans; Lomust | 1987 |
Role of fluroacetate in the toxicity of 2-fluroethylnitrosoureas.
Topics: Animals; Cell Survival; Chromatography, Gas; Female; Fluoroacetates; Kidney; Liver; Lomustine; Lymph | 1985 |
The binding of 14C labelled 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) to macromolecules of sensitive and resistant tumours.
Topics: Animals; Binding Sites; Cell Line; DNA, Neoplasm; Female; Lomustine; Lymphoma; Mice; Neoplasm Protei | 1974 |